SANUWAVE Health, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
SANUWAVE Health, Inc. (SNWV) reported Operating Lease, Right-of-Use Asset, Amortization Expense of -$6.22 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2020-08-14
- SANUWAVE Health, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-06-30 was -$3.11K.
- SANUWAVE Health, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-03-31 was -$3.11K.
- SANUWAVE Health, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2019-06-30 was -$1.74K.
- SANUWAVE Health, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2019-03-31 was -$1.74K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month |
|---|---|---|
| 2020-06-30 | -$3.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$6.22K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$3.11K 10-Q · filed 2020-05-15 | |
| 2019-06-30 | -$1.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$3.47K 10-Q · filed 2020-08-14 |
| 2019-03-31 | -$1.74K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |